Protagonist Therapeutics Inc
XBER:PGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Protagonist Therapeutics Inc
XBER:PGF
|
US |
|
CK Asset Holdings Ltd
HKEX:1113
|
HK |
|
B
|
Bank Danamon Indonesia Tbk PT
XMUN:HX9
|
ID |
|
WuXi Biologics (Cayman) Inc
F:1FW1
|
CN |
|
PowerBand Solutions Inc
XTSX:PBX
|
CA |
|
A
|
Avance Gas Holding Ltd
DUS:A07
|
BM |
|
A
|
Alpine Immune Sciences Inc
F:34LA
|
US |
|
Central Pacific Financial Corp
NYSE:CPF
|
US |
|
Liontown Resources Ltd
OTC:LINRF
|
AU |
|
Guangdong Investment Ltd
F:GUG0
|
HK |
|
Franchise Brands PLC
LSE:FRAN
|
UK |
|
Itau Unibanco Holding SA
BOVESPA:ITUB4
|
BR |
|
Implenia AG
SIX:IMPN
|
CH |
|
A
|
Asahi Group Holdings Ltd
SWB:ABW
|
JP |
|
P
|
Prologis Inc
F:POJN
|
US |
|
F
|
Francotyp Postalia Holding AG
XBER:FPH
|
DE |
|
P
|
Pultegroup Inc
DUS:PU7
|
US |
|
Asure Software Inc
NASDAQ:ASUR
|
US |
|
EVgo Inc
NASDAQ:EVGO
|
US |
|
A
|
Aptose Biosciences Inc
F:LTIA
|
CA |
|
Arkema SA
OTC:ARKAF
|
FR |
|
SSAB AB
OTC:SSABF
|
SE |
|
B
|
Bird Construction Inc
OTC:BIRDF
|
CA |
|
B
|
Betmakers Technology Group Ltd
OTC:TPBTF
|
AU |
Multiples-Based Value
The Multiples-Based Value for
Protagonist Therapeutics Inc (PGF) under the Base Case is hidden
EUR.
Compared with the current market price of 75 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.